Center for Translational and Public Health Genomics
The Center for Translational and Public Health Genomics (CTPHG) was created to bridge the gap between epidemiologic discoveries and their translation into clinical and public health applications to benefit cancer patients, individuals at elevated risk for cancer, and the general population. Leveraging the large patient population and healthy controls with comprehensive data and biospecimens and the rapid development of new high-throughput biomedical technologies that generate genomic information at an unprecedented pace, the Center contributes to the institutional commitment of personalized medicine by providing expertise in translational genomics for cancer risk, prevention interventions, progression from pre-malignancy to cancer, pharmacogenomics to predict therapeutic response, and survivorship and quality of life. More information
Cancer Prevention and Population Sciences Faculty in the News
- MD Anderson study reveals new insight into DNA repair - Guang Peng, M.D., Ph.D.
- 1 in 3 colon cancers in young people has genetic link - Eduardo Vilar-Sanchez, M.D., Ph.D.
- Study reveals that women who sit too much have increased risk of cancer - Karen Basen-Engquist, Ph.D., M.P.H.
- Cancer prevention as our first best hope: Action in prevention research and cancer control - Ernest Hawk, M.D., M.P.H.